Ottobock is dedicated to assisting individuals in maintaining or regaining their freedom of movement—a mission that has remained steadfast for over a century. As a leading med-tech company, Ottobock continuously sets new standards in prosthetics and orthotics. Since introducing the groundbreaking C-Leg in 1997—the world's first leg prosthesis controlled entirely by microprocessors—Ottobock has consistently pushed the boundaries of innovation. The C-Brace mechatronic orthosis, designed to aid individuals affected by paralysis from neurological conditions like multiple sclerosis and strokes, showcases unique technology that enables users to stand and walk again. In addition to prosthetics and orthotics, Ottobock's portfolio includes wheelchairs and exoskeletons, which alleviate strain for individuals in physically demanding occupations and enhance ergonomics in industrial, logistics, and trade settings. Ottobock adopts an integrated approach, combining innovative products with personalized treatment to address the needs of its users. With over 240 patient care centers worldwide, Ottobock fosters close relationships with users, driving continuous improvement of existing solutions and the development of new ones. By embracing digitalization in the fitting process, Ottobock enhances efficiency and comfort, benefiting external orthopaedics companies and medical supply firms alike. With a stable growth trajectory spanning many years, Ottobock achieved sales exceeding one billion euros for the first time in 2019. This success is attributable to the dedication of over 8,000 employees worldwide. Coordinating international operations from its headquarters in Duderstadt, Germany, Ottobock maintains a global presence through a network of research, production, and logistics facilities, as well as sales and service entities in over 50 countries. This global-local synergy enables Ottobock to deliver genuine international solutions with a personalized touch.